vanadates has been researched along with Diabetic Nephropathies in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Abboud, HE; Biswas, P; Choudhury, GG; Fouqueray, B; Grandaliano, G; Wenzel, UO | 1 |
Klein, DJ; Robertson, RP | 1 |
Acara, M; Bennett, MI; Lohr, JW; McReynolds, J; Pochal, MA; Willsky, GR | 1 |
1 review(s) available for vanadates and Diabetic Nephropathies
Article | Year |
---|---|
Treatment of diabetes mellitus.
Topics: Animals; Antihypertensive Agents; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Humans; Insulin; Islets of Langerhans Transplantation; Pancreas Transplantation; Rats; Rats, Inbred SHR; Risk Factors; Vanadates | 1992 |
2 other study(ies) available for vanadates and Diabetic Nephropathies
Article | Year |
---|---|
Activation of mesangial cells by the phosphatase inhibitor vanadate. Potential implications for diabetic nephropathy.
Topics: Calcium; Diabetic Nephropathies; DNA; Dose-Response Relationship, Drug; Enzyme Activation; Glomerular Mesangium; Humans; Inositol Phosphates; Mitogens; Phosphorylation; Platelet-Derived Growth Factor; Protein Kinase C; Protein Tyrosine Phosphatases; RNA, Messenger; Tetradecanoylphorbol Acetate; Type C Phospholipases; Tyrosine; Vanadates | 1995 |
Effect of vanadate on renal hypertrophy and sorbitol accumulation in streptozotocin induced diabetes in rats.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Hypertrophy; Inositol; Kidney; Male; Organ Size; Rats; Rats, Inbred Strains; Sorbitol; Vanadates | 1991 |